Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Agennix, a privately owned Houston-based biopharmaceutical company, is developing patented protein and peptide drug candidates including talactoferrin alfa (talactoferrin), an immunomodulatory protein. Talactoferrin appears to be safe and well tolerated after administration to over 500 people, and appears to be effective in treating cancer and diabetic foot ulcers. Agennix holds 76 patents including broad composition of matter coverage. The Company has seven Phase II human clinical trials currently underway in the treatment of cancer and diabetic foot ulcers, with company sponsored U.S. INDs in both areas. ( www.agennix.com )
Agennix Inc
8 Greenway Plaza Suite 910
Houston, Texas 77046
USA
Tel: (713) 552-1091
Fax: (713) 552-0795